Diwei Zheng

机构：University of Electronic Science and Technology of China, Chinese Academy of Sciences, Guangzhou Institutes of Biomedicine and Health, Wuhan University, Institute of Process Engineering, Ministry of Education, University of Chinese Academy of Sciences, Hubei University, University of Hong Kong · ORCID：0000-0001-8888-9630

发表论文 113 篇 · 总被引 8586 次 · h-index 48

代表论文

• Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis (2024 · Cell Host & Microbe · 被引 178)
• Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy (2023 · ACS Nano · 被引 80)
• Inhalable Capsular Polysaccharide‐Camouflaged Gallium‐Polyphenol Nanoparticles Enhance Lung Cancer Chemotherapy by Depleting Local Lung Microbiota (2023 · Advanced Materials · 被引 60)
• Deep-penetration functionalized cuttlefish ink nanoparticles for combating wound infections with synergetic photothermal-immunologic therapy (2023 · Biomaterials · 被引 46)
• Engineering a Near-Infrared Spiro-Based Aggregation-Induced Emission Luminogen for DNAzyme-Sensitized Photothermal Therapy with High Efficiency and Accuracy (2024 · Journal of the American Chemical Society · 被引 43)
• Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma (2024 · Molecular Therapy Oncology · 被引 35)